Hospital Readmissions are Not the Enemy

http://www.healthleadersmedia.com/quality/hospital-readmissions-are-not-enemy?spMailingID=9540993&spUserID=MTMyMzQyMDQxMTkyS0&spJobID=1001565259&spReportId=MTAwMTU2NTI1OQS2

PostHospitalSyndromePostHospitalSyndromePostHospitalSyndrome

The Centers for Medicare & Medicaid Services has all but declared war on readmissions. But one researcher suggests that the relationship between readmission rates and quality is flawed.

‘Superbug’ scourge spreads as U.S. fails to track rising human toll

http://www.reuters.com/investigates/special-report/usa-uncounted-surveillance/

Fifteen years after the U.S. declared drug-resistant infections to be a grave threat, the crisis is only worsening, a Reuters investigation finds, as government agencies remain unwilling or unable to impose reporting requirements on a healthcare industry that often hides the problem.

http://www.healthleadersmedia.com/quality/hidden-toll-drug-resistant-superbugs-0?spMailingID=9540993&spUserID=MTMyMzQyMDQxMTkyS0&spJobID=1001565259&spReportId=MTAwMTU2NTI1OQS2#

 

We’re closer to a publicly funded health care system than you think

http://blog.academyhealth.org/were-closer-to-a-publicly-funded-health-care-system-than-you-think/

Image result for We’re closer to a publicly funded health care system than you think

Every time health care reform comes up for debate, I see people arguing about whether a publicly or privately funded system would be better. The Affordable Care Act, in an attempt to forestall this debate, decided to split the baby, and give half of its newly insured beneficiaries public insurance (Medicaid) and half private insurance (insurance exchanges). But this isn’t really true. Yes, the half of people getting expanded Medicaid are getting public insurance, but the vast majority of people getting private insurance are also getting public funds (subsidies) in order to purchase their private insurance.

In other words, even though we expanded private insurance, we’re doing it with taxpayer dollars. Overall, the reduction in the uninsured was due to mostly public spending, with relatively little private spending overall. This isn’t rare in the US health care system. A recently released policy brief from the UCLA Center for Health Policy Research, “Public Funds Account for Over 70 Percent of Health Care Spending in California“, explains this quite well.

If you just look at a simple analysis of Medicaid, Medicaid, and CHIP, you might find that about 45% (or less than half) of total US health care spending is public. But that ignores a ton of health care spending that is also paid for with public funds outside those programs. In an effort to document the different, researchers looked at health care spending in California. They included four major public funding categories:

  1. Payments for public health insurance programs (like Medicare and Medicaid)
  2. Government payments for health insurance coverage for public employees (like me at Indiana University, for instance)
  3. Tax subsidies for employer-sponsored insurance and those purchasing exchange plans who earn less than 400% of the poverty line
  4. County health care expenditures

 

Candidates Decry High Drug Prices, But They Have Few Options For Voters

http://khn.org/news/candidates-decry-high-drug-prices-but-they-have-few-options-for-voters/?utm_campaign=KHN%3A+Daily+Health+Policy+Report&utm_source=hs_email&utm_medium=email&utm_content=34504530&_hsenc=p2ANqtz-8jV9oGDFPhUY7AIC7h75jL1KC5hMbGnVXQiBbMw7S-o8a9cNbtaq7e7EyhVHZrYWAX2-Oix7Ha5jcF9E7NZ2gAl0hFHg&_hsmi=34504530

election_voters_drugprices_770

In this year’s presidential campaign, health care has taken a back seat. But one issue appears to be breaking through: the rising cost of prescription drugs.

The blockbuster drugs to treat hepatitis C as well as dramatic price increases on older drugs, most recently the EpiPen allergy treatment, have combined to put the issue back on the front burner.

Democrat Hillary Clinton just issued a lengthy proposal to address what her campaign calls “unjustified price hikes for long-available drugs.” That’s in addition to a broader proposal to address high drug prices the campaign put out last fall.

Republican Donald Trump, meanwhile, has said little about health care since announcing his candidacy in 2015, but he has several times called for a change in law to allowMedicare to negotiate drug prices for the population it serves.

Here are five reasons why this issue is back — and why it is so difficult to solve.

The Missing Debate Over Rising Health-Care Deductibles

http://blogs.wsj.com/washwire/2016/09/18/the-missing-debate-over-rising-health-care-deductibles/?utm_campaign=KHN%3A+Daily+Health+Policy+Report&utm_source=hs_email&utm_medium=email&utm_content=34504530&_hsenc=p2ANqtz–cbQhbJAJ2j-K8I_jQv3kzC6RJuMdvGplQjAJSD–Kc6wYpIZ2CPkYbSLYxHgIpMaHkl9CnoCCH3BO8Sf-cUroX2PTig&_hsmi=34504530

 

Progressives push for ‘public option’ health plan

http://www.usatoday.com/story/news/2016/09/15/progressives-push-public-option-health-plan/90375964/

Image result for public health plan option

Progressive senators and activists are launching a campaign Thursday calling for every American to have the choice of a public health insurance option.